Comparison of ovine, bovine and porcine mucosal heparins and low molecular weight heparins by disaccharide analyses and 13C NMR

Carbohydrate Polymers

Volumn 33, Issue 1, 1997, Pages 5-11

  Watt, D K ^a   Yorke, S C ^a   Slim, G C ^b  

^a New Zealand Pharmaceuticals Limited   (New Zealand)

^b CALLAGHAN INNOVATION   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COMPOSITION; INORGANIC ACIDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL ROTATION; PEROXIDES; POLYMERIZATION; SUGAR (SUCROSE);

BOVINE HEPARIN; DISACCHARIDE; ELEMENTAL ANALYSIS; LOW MOLECULAR WEIGHT HEPARIN; NITROUS ACID; OVINE HEPARIN; PORCINE HEPARIN;

POLYSACCHARIDES;

EID: 0031144783     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0144-8617(97)00042-8     Document Type: Article

References (15)

1. Braud, C., Vert, M. and Granger, P. (1985) Structure polyélectrolytique et activité anticoagulante de fractions d'héparine obtenues par chromatographie d'échange d'ions. Carbohydr. Res. 141, 121-136.
2. Casu, B., Johnson, E.A., Mantovani, M., Mulloy, B., Oreste, P., Pescador, R., Prino, G., Torri, G. and Zoppetti, G. (1983) Correlation between structure, fat-clearing and anti-coagulant properties of heparins and heparan sulphates. Arzneimittel-Forschung/Drug Research 33, 135-142.
3. Coccheri, S. (1990) Low molecular weight heparins: an introduction. Haemostasis 20(1), 74-80.
4. Desai, U.R., Wang, H. and Linhardt, R.J. (1993) Substrate specificity of heparin lyases from Flavobacterium heparinum. Arch. Biochem. Biophys. 306, 468.
5. 13C nuclear magnetic resonance spectroscopy. Carbohydr. Res. 255, 193-212.
6. 13C NMR spectroscopy. Macromolecules, 1001-1007.
7. Linhardt, R.J. (1992) Chemical and enzymatic methods for the depolymerisation and modification of heparin. In Carbohydrates - Synthetic Methods and Applications in Medicinal Chemistry, ed. H. Ogura, A. Hasregawa and T. Suami, pp. 385-401. Kodiansha, Tokyo, and VCH, Weinheim.
8. Loganathan, D., Wang, H.M., Mallis, L.M. and Linhardt, R.J. (1990) Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources. Biochemistry 29, 4362-4368.
9. Rice, K.G. and Linhardt, R.J. (1989) Study of structurally defined oligosaccharide substrates of heparin and heparan monosulphate lyases. Carbohydr. Res. 190, 219-233.
10. Shively, J.E. and Conrad, H.E. (1976) Formation of anhydrosugars in the chemical depolymerisation of heparin. Biochemistry 15, 3932-3942.
11. Slim, G.C., Furneaux, R.H. and Yorke, S.C. (1994) A procedure for the analysis of glycosaminoglycan mixtures based on digestion by specific enzymes. Carbohydr. Res. 225, 285-293.
12. Taylor, G.J., Yorke, S.C. and Harding, D.R.K. (1995) Glycosaminoglycan specificity of a heparin-binding peptide. Peptide Res. 8, 286-293.
13. USP (1989) Heparin sodium. In The United States Pharmacopeia, 22nd revision, p. 633.
14. Uchiyama, H. and Nagasawa, K. (1991) Changes in the structure and biological property of N,O sulphate transferred N resulphated heparin. J. Biol. Chem. 266, 6756-6760.
15. Volpi, N., Mascellani, G. and Bianchini, P. (1992) Low molecular weight heparins (5 kDa) and oligoheparins (2 kDa) produced by gel permeation enrichment or radical process: comparison of structures and physicochemical and biological properties. Analytical Biochem. 200, 100-107.